Opportunistic Infections Citation List:
October 28, 2009 -November 10, 2009
Opportunistic protozoa COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. Anti-parasitic action and elimination of intracellular Toxoplasma gondii in the presence of novel thiosemicarbazone and its 4-thiazolidinone derivatives.
Carvalho CS, de Melo EJ.
Braz J Med Biol Res. 2009 Nov 6. pii: S0100-879X2009005000038. [Epub ahead of print]
PMID: 19893994
2. In-vitro and in-vivo activity of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii.
Bajohr LL, Ma L, Platte C, Liesenfeld O, Tietze LF, Groß U, Bohne W.
Antimicrob Agents Chemother. 2009 Nov 2. [Epub ahead of print]
PMID: 19884369
3. Synthesis and biological evaluation of biguanide and dihydrotriazine derivatives as potential inhibitors of dihydrofolate reductase of opportunistic microorganisms.
Bag S, Tawari NR, Queener SF, Degani MS.
J Enzyme Inhib Med Chem. 2009 Oct 29. [Epub ahead of print]
PMID: 19874136
4. Drug discovery targeting epigenetic codes: the great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis.
Unoki M, Brunet J, Mousli M.
Biochem Pharmacol. 2009 Nov 15;78(10):1279-88. Epub 2009 Jun 6.
PMID: 19501055
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
5. Design, Synthesis, and Antifungal Activity of Novel Conformationally Restricted Triazole Derivatives.
Wang W, Sheng C, Che X, Ji H, Miao Z, Yao J, Zhang W.
Arch Pharm (Weinheim). 2009 Nov 6. [Epub ahead of print]
PMID: 19899102
6. Synthesis, cytotoxicity by bioluminescence inhibition, antibacterial and antifungal activity of ([1,2,4]Triazolo[1,5-c]quinazolin-2-ylthio)carboxylic acid amides.
Antipenko LN, Karpenko AV, Kovalenko SI, Katsev AM, Komarovska-Porokhnyavets EZ, Novikov VP.
Arch Pharm (Weinheim). 2009 Nov;342(11):651-62.
PMID: 19882690
7. Synthesis, stereochemistry and antimicrobial studies of novel oxime ethers of aza/diazabicycles.
Parthiban P, Aridoss G, Rathika P, Ramkumar V, Kabilan S.
Bioorg Med Chem Lett. 2009 Oct 29. [Epub ahead of print]
PMID: 19879756
8. Antifungal effect with apoptotic mechanism(s) of Styraxjaponoside C.
Park C, Woo ER, Lee DG.
Biochem Biophys Res Commun. 2009 Oct 28. [Epub ahead of print]
PMID: 19878645
9. In vitro interactions between primycin and different statins in their effects against some clinically important fungi.
Nyilasi I, Kocsube S, Pesti M, Lukacs G, Papp T, Vagvolgyi C.
J Med Microbiol. 2009 Oct 29. [Epub ahead of print]
PMID: 19875509
10. Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.
Slade D, Galal AM, Gul W, Radwan MM, Ahmed SA, Khan SI, Tekwani BL, Jacob MR, Ross SA, Elsohly MA.
Bioorg Med Chem. 2009 Dec 1;17(23):7949-57. Epub 2009 Oct 30.
PMID: 19879765 [PubMed - in process]
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
11. Panning for chemical gold: marine bacteria as a source of new therapeutics.
Williams PG.
Trends Biotechnol. 2008 Nov 18. [Epub ahead of print]
PMID: 19022511 [PubMed - as supplied by publisher]
12. Efavirenz Mannich bases: Synthesis, anti-HIV and antitubercular activities.
Sriram D, Banerjee D, Yogeeswari P.
J Enzyme Inhib Med Chem. 2008 Nov 13:1. [Epub ahead of print]
PMID: 19005871 [PubMed - as supplied by publisher]
Citations from the ISI Web of Knowledge Listings for O.I.
13. Geng, CA, et al
Swerilactones C and D, anti-HBV New Lactones from a Traditional Chinese Herb: Swertia mileensis
ORGANIC LETTERS 2009 (Nov.) 11: 4838 - 4841
14. Ozcelik, B, et al
Antiviral and antimicrobial activities of three sesquiterpene lactones from Centaurea solstitialis L. ssp solstitialis
MICROBIOLOGICAL RESEARCH 2009 164: 545 - 552
15. Yenjai, C, et al.
Structural Modification of 5,7-Dimethoxyflavone from Kaempferia parviflora and Biological Activities
ARCHIVES OF PHARMACAL RESEARCH 2009 (Sept) 32: 1179 - 1184 PD